计量化学疗法的未来:药物重定向的实验和计算方法
Yousef A Abdelrady1, Hayam S Thabet2, Ahmed M Sayed3,4
1Institute of Pharmaceutical Sciences, University of Freiburg, 79104, Freiburg, Germany.
Pharmacological reports : PR
|October 21, 2024
概括
计量化学疗法 (MC) 为传统化疗提供了一种毒性较低的替代方案. 药物重新定位 (DR) 加快了新的MC药物的发现,以克服耐药性并改善癌症治疗.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 药物发现 药物发现 药物发现
背景情况:
- 计量化学疗法 (MC) 涉及持续的,低剂量的抗癌药物管理,与最大耐受剂量 (MTD) 方案形成对比.
- 当与其他治疗方法相结合时,MC可提高治疗效果并最大限度地降低毒性,在各种癌症中表现出多功能性.
- 耐药性仍然是一个重大挑战,推动了对新型抗癌剂和高效药物发现方法的需求.
研究的目的:
- 审查在癌症治疗中计量化学疗法 (MC) 的机制和应用.
- 探索药物再利用 (DR) 作为一种具有成本效益的策略,用于识别新的MC代理物.
- 讨论开发瘤学MC和DR策略的挑战和未来方向.
主要方法:
- 审查关于MC机制,临床应用和耐药性的现有文献.
- 对药物发现和虚拟查的实验和计算方法的分析,包括蛋白质结合测试,细胞毒性测试和关联分析.
- 检查药物重定向策略,包括基于相似性,基于网络和目标基因的方法.
主要成果:
- MC利用多种机制对抗各种癌症,为MTD化疗提供了一个有前途的替代方案.
- 药物重定位 (DR) 是一种可行的,具有成本效益的方法,可以加快新型抗癌药物的识别.
- 一系列的实验和计算技术有助于对潜在的候选药物进行虚拟查.
结论:
- 计量化学疗法 (MC) 是一种有价值的策略,有可能在癌症治疗中提高疗效和降低毒性.
- 药物重新定位 (DR) 显著简化了药物发现管道,为新的癌症治疗提供了更快,更经济的途径.
- 对MC机制的持续研究和包括DR在内的创新药物发现对于克服耐药性和推进癌症治疗至关重要.
更多相关视频
08:57Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
Published on: October 5, 2017
10.9K
09:41An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
8.6K
相关概念视频
01:26Drug Discovery: Overview
7.5K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.5K
01:28Structure-Activity Relationships and Drug Design
622
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
622
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:26Targets for Drug Action: Overview
6.1K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.1K
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K